192 related articles for article (PubMed ID: 23790174)
1. Clinical significance of ascites in epithelial ovarian cancer.
Huang H; Li YJ; Lan CY; Huang QD; Feng YL; Huang YW; Liu JH
Neoplasma; 2013; 60(5):546-52. PubMed ID: 23790174
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring.
Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
J Ovarian Res; 2015 Aug; 8():58. PubMed ID: 26282935
[TBL] [Abstract][Full Text] [Related]
3. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer.
Hou S; Du P; Wang P; Wang C; Liu P; Liu H
Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CPS1-IT1 is a positive prognostic factor and inhibits epithelial ovarian cancer tumorigenesis.
Wang YS; Ma LN; Sun JX; Liu N; Wang H
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3169-3175. PubMed ID: 28770969
[TBL] [Abstract][Full Text] [Related]
5. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
Li T; Xue H; Guo Y; Guo K
Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
7. Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.
Omichi C; Nakamura K; Haraga J; Masuyama H; Hiramatsu Y
Cancer Med; 2016 Jun; 5(6):1074-80. PubMed ID: 26929186
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective.
Elstrand MB; Sandstad B; Oksefjell H; Davidson B; Tropé CG
Acta Obstet Gynecol Scand; 2012 Mar; 91(3):308-17. PubMed ID: 22050605
[TBL] [Abstract][Full Text] [Related]
10. The impact of pelvic retroperitoneal invasion and distant nodal metastases in epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Pérez-Milán F; Ortiz-Quintana L
Surg Oncol; 2014 Mar; 23(1):40-4. PubMed ID: 24183480
[TBL] [Abstract][Full Text] [Related]
11. The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
Ataseven B; Harter P; Grimm C; Heitz F; Heikaus S; Traut A; Kahl A; Kurzeder C; Prader S; du Bois A
Gynecol Oncol; 2016 Aug; 142(2):243-7. PubMed ID: 27208538
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
13. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.
Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H
Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495
[TBL] [Abstract][Full Text] [Related]
14. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.
Paulsen T; Kærn J; Tropé C
Gynecol Oncol; 2011 Jul; 122(1):83-8. PubMed ID: 21435701
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.
Hamilton CA; Miller A; Casablanca Y; Horowitz NS; Rungruang B; Krivak TC; Richard SD; Rodriguez N; Birrer MJ; Backes FJ; Geller MA; Quinn M; Goodheart MJ; Mutch DG; Kavanagh JJ; Maxwell GL; Bookman MA
Gynecol Oncol; 2018 Feb; 148(2):275-280. PubMed ID: 29195926
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.
Zhou S; Tang L; Wang H; Dai J; Zhang J; Shen L; Ng SW; Berkowitz RS
Gynecol Oncol; 2013 Oct; 131(1):69-76. PubMed ID: 23820113
[TBL] [Abstract][Full Text] [Related]
17. High expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancer.
Deng Y; Jiang L; Wang Y; Xi Q; Zhong J; Liu J; Yang S; Liu R; Wang J; Huang M; Tang C; Su M
Pathol Res Pract; 2016 Apr; 212(4):239-46. PubMed ID: 26920249
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of cortactin protein in ovarian neoplasms.
Li A; Zhang L; Zhang X; Jin W; Ren Y
Clin Transl Oncol; 2016 Feb; 18(2):220-7. PubMed ID: 26243395
[TBL] [Abstract][Full Text] [Related]
19. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
[TBL] [Abstract][Full Text] [Related]
20. Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer.
Ataseven B; du Bois A; Harter P; Prader S; Grimm C; Kurzeder C; Schneider S; Heikaus S; Kahl A; Traut A; Heitz F
Int J Gynecol Cancer; 2016 Nov; 26(9):1594-1600. PubMed ID: 27654263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
